Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person Wlodarska, Iwona

Class:Id	Person:9672480
_displayName	Wlodarska, Iwona
_timestamp	2019-12-26 13:08:45
created	[InstanceEdit:9672485] Rothfels, Karen, 2019-12-26
firstname	Iwona
initial	I
surname	Wlodarska
(author)	[LiteratureReference:9672488] A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome [LiteratureReference:9710725] ALK activation by the CLTC-ALK fusion is a recurrent event in large B-cell lymphoma [LiteratureReference:9710762] Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with the variant RNF213-, ATIC- and TPM3-ALK fusions is characterized by copy number gain of the rearranged ALK gene [LiteratureReference:9711846] Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor
[Change default viewing format]

No pathways have been reviewed or authored by Wlodarska, Iwona (9672480)